This is ALL THINGS CONSIDERED from NPR News. I'm Melissa Block. In Britain, the radical cleric Abu Hamza has lost his final battle to avoid extradition to the United States. Britain's high court judges ruled today that Hamza and four other suspected terrorists must now be sent to the U.S. to face trial on terror charges related to al-Qaida. That ends a legal battle that, in Hamza's case, has lasted nearly 14 years. Vicki Barker reports from London.
The new jobs report, out today, shows a sharp drop in the unemployment rate. But millions of Americans are, of course, still looking for work. Often, the bridge between them and a good job is a training program to help give them a new set of skills. Programs to retrain America's workforce got quite a bit of attention in Wednesday's presidential debate, and NPR's Yuki Noguchi reports on one of them here in Washington.
For the past decade, al-Qaida has been a top-down organization.
Letters seized at Osama bin Laden's compound in Pakistan showed that he was a hands-on manager, approving everything from operations to leadership changes in affiliate groups.
But there's early intelligence that al-Qaida may have had a small role in the attack on the U.S. Consulate in Benghazi, Libya, which killed four Americans, including Ambassador Chris Stevens, on Sept. 11.
If al-Qaida involvement is confirmed, it may signal that al-Qaida has changed.
Originally published on Fri October 5, 2012 2:24 pm
The news that the cost of personal genome sequencing will soon drop as low as $1,000 has generated a quite a bit of interest and concern — from medical researchers, biotech companies, bioethicists and the average consumer alike.
NPR's Rob Stein explored many of the implications of this technology in his four-part series "The $1,000 Genome." They're complicated, to say the least.